Forbion Capital Partners
Forbion is a Europe-based venture capital firm focused on building and financing life sciences and bioeconomy companies. The firm combines investment capital with drug-development and company-building expertise, operates multiple fund platforms (Ventures, Growth Opportunities, BioEconomy) and is a signatory to the UN Principles for Responsible Investment. Source content indicates Forbion manages €5bn and has an established track record in life-sciences investing across multiple funds.
Industries
Nr. of Employees
small (1-50)
Forbion Capital Partners
PO Box 5187, 1410 AD Naarden, The Netherlands; Visiting address: Gooimeer 2-35, 1411 DC Naarden
Portfolio
Two proprietary AAV-based large gene delivery platforms (dual hybrid and AAV intein).
#Gene therapy / AAV-based gene delivery
Focus on vectorized antibodies for CNS diseases.
#Integrated gene therapy (vectorized antibodies for CNS)
Targets cancers dependent on synthetic lethality mechanisms.
#Oncology / synthetic lethality approaches
Develops plant-based products with fibrous texture.
#Sustainable food technology / plant-based foods
Develops biologics to modulate cytokine function for cancer patients.
#Biopharmaceuticals / biologics
Develops first-in-class immuno-modulatory antibodies for cancer.
#Immuno-oncology / antibody therapeutics
Two proprietary AAV-based large gene delivery platforms (dual hybrid and AAV intein).
#Gene therapy / AAV-based gene delivery
Focus on vectorized antibodies for CNS diseases.
#Integrated gene therapy (vectorized antibodies for CNS)
Targets cancers dependent on synthetic lethality mechanisms.
#Oncology / synthetic lethality approaches
Develops plant-based products with fibrous texture.
#Sustainable food technology / plant-based foods
Develops biologics to modulate cytokine function for cancer patients.
#Biopharmaceuticals / biologics
Develops first-in-class immuno-modulatory antibodies for cancer.
#Immuno-oncology / antibody therapeutics